Marché Fermé -
Autres places de cotation
|
Après clotûre 21:57:46 | |||
17,6 EUR | -0,56 % | 17,56 | -0,23 % |
12/04 | AVIS D'ANALYSTES DU JOUR : Airbus, Publicis, Amundi, ASML, Michelin, OVH, VAT Group, Givaudan... | |
11/04 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 |
Métier
Nombre d'employés: 3 282
Ventes par activité
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Fagron North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
Fagron EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Fagron Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Ventes par région
EUR en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99 % |
EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08 % |
Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Karen Berg
IRC | Investor Relations Contact | - | 01/09/21 |
Marc van der Aa
PRN | Corporate Officer/Principal | - | - |
Johan Verlinden
LAW | General Counsel | - | 01/04/13 |
Corporate Officer/Principal | 54 | 01/01/08 | |
Celine Caveye
HRO | Human Resources Officer | - | 01/01/11 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Koen Hoffman
CHM | Chairman | 56 | 01/08/16 |
Director/Board Member | 64 | 01/01/19 | |
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Director/Board Member | 53 | 09/05/22 | |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Neeraj Sharma
BRD | Director/Board Member | 52 | 09/05/22 |
Director/Board Member | 52 | 01/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 73 228 904 | 69 227 472 ( 94,54 %) | 241 999 ( 0,3305 %) | 94,54 % |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
FAGRON as
FAGRON as Pharmaceuticals: MajorHealth Technology FAGRON as operates as wholesaler of pharmaceutical raw materials, creams and packaging to pharmacists. The company was founded on May 11, 1992 and is headquartered in Olomouc, Czech Republic. |
Pharmaceuticals: Major
|
Arseus Capital NV
Arseus Capital NV Financial ConglomeratesFinance Part of Fagron NV, Arseus Capital NV provides financial services. The private company is based in Nazareth, Belgium. The CEO of the Belgian company is Cornelia de Jong. |
Financial Conglomerates
|
Dr. Kulich Pharma sro
Dr. Kulich Pharma sro Pharmaceuticals: MajorHealth Technology Dr. Kulich Pharma sro engages in the pharmaceuticals industry. It offers drugs, pharmaceutical materials, chemicals, as well as laboratory services. The company was founded by Jan Kulich in 1992 and is headquartered in Hradec Kralove, Czech Republic. |
Pharmaceuticals: Major
|
Fagron BV
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Bénéfices annuels - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
+5,96 % | 1,38 Md | |
+27,97 % | 672 Md | |
+23,52 % | 550 Md | |
-7,02 % | 351 Md | |
+14,85 % | 317 Md | |
+6,25 % | 292 Md | |
+2,38 % | 211 Md | |
-0,67 % | 203 Md | |
-10,27 % | 194 Md | |
-11,81 % | 144 Md |
- Bourse
- Actions
- Action FAGR
- Société Fagron N.V.